Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray.

Detection Principle
ImmunoAssay-Antibody
Target
IgG, IgM vs S, N, RBD, S1, S2, PLpro
Testing Method Category
Other
Testing Method
microarray
Testing Method - Additional Info
A coronavirus antigen microarray (COVAM) was constructed containing 61 antigens that are causes of acute respiratory infections, including 11 antigens from SARS-CoV-2.
Reported Performance
Sensitivity: 56.29% (IgG vs S1), 58.94% (IgM vs RBD), 87.8% (combination of IgG and IgM, >7 dpo); Specificity: 98.49% (IgG vs S1), 98.73% (IgM vs RBD), 98.9% (combination of IgG and IgM, >7 dpo)
Sample Size
188 samples
Peer-reviewed
yes

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements